Company news
Wai Chun Bio-technology Ltd. (HKEX:660) news
Wai Chun Bio-technology Ltd. news releases on 6ix. Latest, Oct 2, 2026: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30…
Press releases & updates
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2026
October 2, 2026
EXCHANGE NOTICE - SUSPENSION OF TRADING
October 1, 2026
(I) DELAY IN PUBLICATION OF THE 2026 ANNUAL RESULTS; (II) POSSIBLE DELAY IN DESPATCH OF THE 2026 ANNUAL REPORT; AND (III) SUSPENSION OF TRADING
October 1, 2026
Wai Chun Bio Technology : RESIGNATION OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
May 10, 2021
Wai Chun Bio Technology : APPOINTMENT OF CHIEF FINANCIAL OFFICER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
May 5, 2021
Wai Chun Bio Technology : RESINGATION OF CHIEF FINANCIAL OFFICCER, COMPANY SECRETARY AND AUTHORISED REPRESENTATIVE
April 30, 2021
Wai Chun Bio Technology : 2020 ANNUAL RESULTS ANNOUNCEMENT
April 28, 2021
Wai Chun Bio Technology : Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 March 2021
April 8, 2021
Wai Chun Bio Technology : DELAY IN PUBLICATION OF THE AUDITED RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020
March 31, 2021
Wai Chun Bio Technology : CHANGE OF AUDITOR
February 25, 2021
Wai Chun Bio Technology : INTERIM REPORT 2020
September 22, 2020
Wai Chun Bio Technology : PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER SPECIFIC MANDATE
September 21, 2020
Wai Chun Bio Technology : LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
September 14, 2020
Wai Chun Bio Technology : RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR
September 14, 2020
Wai Chun Bio Technology : CANCELLATION OF PROPOSED ISSUE OF CONVERTIBLE BONDS
September 9, 2020
Wai Chun Bio Technology : Change of Company Secretary, Authorised Representative and Chief Financial Officer
August 10, 2020